Psyllium: Cholesterol and Heart Health

Of everything psyllium is used for, its effect on cholesterol is the most precisely measured. Dozens of randomised trials have tested it, independent groups have pooled them more than once, and two of the world's major medicines and food regulators have written the finding into their rules. The effect is real, consistent and modest: on average, a daily dose of around 10 g lowers low-density lipoprotein (LDL) (“bad”) cholesterol by about a third of a millimole per litre.

This page sets out what those trials found, how a fibre that is never absorbed can change a blood test, what happened when psyllium was added to statins, what the US health claim actually says, and the one large gap in the evidence: nobody has yet run a trial long enough to count heart attacks.


Table of Contents

  1. In Short
  2. How a Gel Lowers Cholesterol
  3. The 28-Trial Meta-Analysis
  4. The 2024 Plantago Meta-Analysis
  5. The 2025 Dose-Response Meta-Analysis
  6. Thirty Years of Consistent Results
  7. Psyllium in Children With High Cholesterol
  8. Psyllium Added to Statins
  9. What the U.S. Food and Drug Administration Health Claim Says
  10. Triglycerides, High-Density Lipoprotein and Blood Pressure
  11. What the Evidence Cannot Yet Say
  12. Key Research Papers
  13. Connections
  14. Featured Videos

In Short

How a Gel Lowers Cholesterol

Psyllium is not absorbed, so it cannot act on the liver directly. Its effect starts in the small intestine.

A 2017 review of fibre physics by McRorie and McKeown reports that the cholesterol-lowering effect of soluble fibres is “highly correlated with the viscosity” of the fibre. Gel-forming fibres — psyllium, beta-glucan from oats and barley, raw guar gum — lower cholesterol in trials. Soluble fibres that do not form a gel (inulin, fructo-oligosaccharides, wheat dextrin) and insoluble fibres (wheat bran) do not.

The explanation usually given in the fibre literature is the bile-acid cycle. The liver makes bile acids from cholesterol and releases them into the gut to digest fat; most are normally reabsorbed lower down and recycled. A thick gel traps some of those bile acids and carries them out in the stool. To replace them, the liver draws more cholesterol out of the blood, and low-density lipoprotein levels fall. The site's bile acids animation shows the cycle that this interrupts.

That mechanism has two practical consequences that the trials bear out. First, the effect depends on the gel: fibres that do not thicken do not work this way. Second, it is dose-dependent and modest: a fibre can only remove so much bile acid from the gut each day.

The 28-Trial Meta-Analysis

The most-cited modern analysis is Jovanovski and colleagues' 2018 systematic review and meta-analysis in the American Journal of Clinical Nutrition. It searched the major databases up to October 2017 and included randomised controlled trials of at least three weeks, in people with or without high cholesterol.

Non-HDL cholesterol and apolipoprotein B are worth a word. Both capture all the cholesterol-carrying particles that can enter artery walls, not only low-density lipoprotein, which is why the authors called them “alternative lipid targets”. That psyllium moved all three in the same direction makes the finding harder to dismiss as a quirk of one measurement. The authors concluded that psyllium improved both conventional and alternative lipid markers in people with or without high cholesterol.

For readers who want to see their own numbers in context, the Lipid Panel page explains each of these measurements.

The 2024 Plantago Meta-Analysis

A second meta-analysis pooled trials of Plantago consumption more broadly, up to August 2023.

The authors translated the low-density lipoprotein reduction into an estimated 7% lower risk of cardiovascular events. That figure is a calculation based on how low-density lipoprotein relates to heart disease in other research — it was not observed in psyllium trials, none of which counted events.

The 2025 Dose-Response Meta-Analysis

A 2025 systematic review and dose-response meta-analysis pooled 41 randomised controlled trials with 2049 adult participants.

Thirty Years of Consistent Results

The modern meta-analyses agree closely with older ones, which is part of what makes this finding credible.

Psyllium cereals, 1997

A 1997 meta-analysis of 12 trials (8 published, 4 unpublished) in 404 adults with mild to moderate high cholesterol, all on a low-fat diet, found that a psyllium-enriched cereal lowered total cholesterol by 0.31 mmol/L (5%) and low-density lipoprotein by 0.35 mmol/L (9%) more than a control cereal, with high-density lipoprotein unaffected. Sex, age and menopausal status made no difference. The later analyses above found almost the same low-density lipoprotein figure.

All soluble fibres, 1999

A 1999 meta-analysis pooled 67 controlled trials of pectin, oat bran, guar gum and psyllium. Each gram of soluble fibre (in the range 2–10 g a day) lowered low-density lipoprotein by about 0.057 mmol/L, and the effects of oat, psyllium and pectin were not significantly different from one another. Triglycerides and high-density lipoprotein did not change. The authors' own conclusion was cautious: the effect is “small within the practical range of intake”, and increasing soluble fibre “can make only a small contribution” to cholesterol-lowering diet therapy.

Breakfast cereals, 2014

A systematic review of 232 articles on breakfast cereals graded the evidence that oat-, barley- or psyllium-based cereals help lower cholesterol at grade A, its highest level (“can be trusted to guide practice”).

Foods ranked, 2021

An umbrella review of 108 systematic reviews and 37 guidelines graded foods high in soluble fibre, such as oats, barley and psyllium, as causing at least moderate (0.20–0.40 mmol/L) low-density lipoprotein reductions with high certainty — the same tier as foods with added plant sterols or stanols and foods high in unsaturated and low in saturated and trans fatty acids.

Psyllium in Children With High Cholesterol

A 2015 randomised, double-blind, placebo-controlled trial in Brazil studied 51 children and adolescents aged 6–19 with mild-to-moderate high cholesterol (hypercholesterolaemia). After a 6-week run-in on the National Cholesterol Education Program Step 2 diet, one group took 7.0 g of psyllium a day for 8 weeks and the control group took the same amount of cellulose.

Psyllium Added to Statins

Statins lower low-density lipoprotein much more than any fibre does. The question one meta-analysis asked was whether psyllium adds anything on top.

Brum and colleagues (2018) found three randomised controlled trials, lasting 4 to 12 weeks, that gave psyllium alongside a statin and compared it with the statin alone. Pooled, the combination lowered cholesterol significantly more (p = 0.001), and the authors reported that adding psyllium produced a low-density lipoprotein reduction “equivalent to doubling the statin dose”.

Two points of context matter here:

The finding is consistent with the mechanism: statins reduce how much cholesterol the liver makes, while a bile-acid-trapping gel increases how much the liver uses, so the two act at different points. The European Medicines Agency monograph states that psyllium (ispaghula husk) can delay the absorption of medicines taken at the same time, naming minerals, vitamin B12, cardiac glycosides, coumarin derivatives, carbamazepine and lithium, and its dosing section sets a gap of at least ½ to 1 hour before or after other medicines. It adds that use with thyroid hormones requires medical supervision because their dose may have to be adjusted, that anti-diabetic treatment may need adjusting in people with diabetes, and that use as an adjuvant in high cholesterol “requires medical supervision”. The site's Cholesterol Management page covers medicines and diet together.

What the U.S. Food and Drug Administration Health Claim Says

In the United States a food label may only link a nutrient to reduced disease risk if the U.S. Food and Drug Administration (FDA) has authorised that specific claim. Soluble fibre from psyllium husk is one of the few that has been authorised. The rule, 21 CFR 101.81, sets out the details:

The same regulations require a psyllium food carrying the claim, if it contains dry or incompletely hydrated husk, to tell consumers it is to be eaten with adequate fluid, to warn of choking, and to tell people with swallowing difficulty not to eat it (21 CFR 101.17(f)). The heart claim and the choking warning come as a pair.

Note what the claim is not: it is a statement about diets and risk, made in the context of a low-saturated-fat diet. It does not say psyllium treats heart disease, and it was not based on trials counting heart attacks.

Triglycerides, High-Density Lipoprotein and Blood Pressure

What the Evidence Cannot Yet Say

Key Research Papers

  1. Jovanovski E, Yashpal S, Komishon A, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. The American journal of clinical nutrition. 2018;108(5):922-932. — 28 trials, 1,924 people; LDL, non-HDL cholesterol and apoB all lower; moderate-to-high certainty. PubMed PMID: 30239559
  2. Zhu R, Lei Y, Wang S, et al. Plantago consumption significantly reduces total cholesterol and low-density lipoprotein cholesterol in adults: A systematic review and meta-analysis. Nutrition research (New York, N.Y.). 2024;126:123-137. — 29 trials, 2,769 people; total and LDL cholesterol lower; HDL and triglycerides unchanged. PubMed PMID: 38688104
  3. Olson BH, Anderson SM, Becker MP, et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. The Journal of nutrition. 1997;127(10):1973-80. — 12 cereal trials, 404 adults; LDL 9% lower. PubMed PMID: 9311953
  4. Brown L, Rosner B, Willett WW, et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. The American journal of clinical nutrition. 1999;69(1):30-42. — 67 trials; soluble fibres from oat, psyllium and pectin lower cholesterol by similar small amounts. PubMed PMID: 9925120
  5. Schoeneck M, Iggman D. The effects of foods on LDL cholesterol levels: A systematic review of the accumulated evidence from systematic reviews and meta-analyses of randomized controlled trials. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2021;31(5):1325-1338. — umbrella review; soluble-fibre foods including psyllium graded high-certainty LDL reducers. PubMed PMID: 33762150
  6. Williams PG. The benefits of breakfast cereal consumption: a systematic review of the evidence base. Advances in nutrition (Bethesda, Md.). 2014;5(5):636S-673S. — oat-, barley- or psyllium-based cereals graded A for lowering cholesterol. PubMed PMID: 25225349
  7. Brum J, Ramsey D, McRorie J, et al. Meta-Analysis of Usefulness of Psyllium Fiber as Adjuvant Antilipid Therapy to Enhance Cholesterol Lowering Efficacy of Statins. The American journal of cardiology. 2018;122(7):1169-1174. — 3 trials; psyllium plus statin lowered cholesterol more than statin alone. PubMed PMID: 30078477
  8. McRorie JW Jr, McKeown NM. Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber. Journal of the Academy of Nutrition and Dietetics. 2017;117(2):251-264. — viscosity of gel-forming fibres explains the cholesterol effect. PubMed PMID: 27863994
  9. Xiao Z, Chen H, Zhang Y, et al. The effect of psyllium consumption on weight, body mass index, lipid profile, and glucose metabolism in diabetic patients: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytotherapy research : PTR. 2020;34(6):1237-1247. — 8 trials in diabetes; triglycerides and LDL lower; very high heterogeneity. PubMed PMID: 31919936
  10. Sartore G, Reitano R, Barison A, et al. The effects of psyllium on lipoproteins in type II diabetic patients. European journal of clinical nutrition. 2009;63(10):1269-71. — 40 people with type 2 diabetes; triglycerides fell only in the psyllium group. PubMed PMID: 19623196
  11. Clark CCT, Salek M, Aghabagheri E, et al. The effect of psyllium supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials. The Korean journal of internal medicine. 2020;35(6):1385-1399. — 11 trials; systolic blood pressure 2.04 mmHg lower. PubMed PMID: 32066221
  12. Juhász AE, Greff D, Teutsch B, et al. Galactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis. The American journal of clinical nutrition. 2023;117(2):266-277. — 46 trials in type 2 diabetes; galactomannans ranked first for LDL and triglycerides. PubMed PMID: 36811560
  13. Gholami Z, Paknahad Z. Psyllium supplementation and lipid profiles: systematic review and dose-response meta-analysis of randomized controlled trials. Genes & nutrition. 2025;20(1):27. — 41 trials, 2049 participants; LDL and total cholesterol lower; triglycerides and HDL not significantly changed. PubMed PMID: 41366295
  14. Ribas SA, Cunha DB, Sichieri R, Santana da Silva LC. Effects of psyllium on LDL-cholesterol concentrations in Brazilian children and adolescents: a randomised, placebo-controlled, parallel clinical trial. The British journal of nutrition. 2015;113(1):134-41. — 51 children and adolescents; 7.0 g a day for 8 weeks; LDL 10.7% lower than control. PubMed PMID: 25391814

PubMed Topic Searches

  1. Psyllium and LDL cholesterol meta-analyses
  2. Psyllium with statins
  3. Psyllium and bile acid excretion
  4. Psyllium and apolipoprotein B

Back to Table of Contents

Connections

Back to Table of Contents